03.04.2019
- Swiss drugmaker Novartis has agreed to buy US biotech IFM Tre in a deal worth nearly $1.6 billion, boosting its portfolio of anti-inflammatory medicines. Novartis will pay $310...
05.03.2019
- Novartis’ ill-advised attempt two years ago to get an inside look at drugs pricing policies of newly elected US president Donald Trump came back to haunt it last week during the...
19.11.2018
- After completing a portfolio review, Novartis has dropped around 20% of its R&D projects as it narrows its focus to the most cutting-edge medicines. Jay Bradner, president of the...
18.10.2018
- Novartis has agreed to buy US biopharma Endocyte, gaining access to radiopharmaceuticals, which the Swiss drugmaker has identified as a key growth driver of its business. Under the...
27.09.2018
- Drugmaker Novartis has announced plans to cut around 2,200 jobs in Switzerland and exit its site in Grimsby, UK, as it transforms its global manufacturing network and product...
19.09.2018
- The pharmaceutical industry has gone through two decades of rapid technological innovations. These include combinatorial chemistry, recombinant DNA technology, development of...
10.09.2018
- Novartis has agreed to sell parts of its Sandoz US portfolio to Aurobindo Pharma USA as the Swiss drugmaker drives ahead with its strategy to focus on higher value medicines...
06.08.2018
- The European Medicines Agency (EMA) is scaling back and suspending some activities as it loses more staff than initially anticipated in advance of its relocation from the UK to the...
